Webinar: CESPHN 2024 Immunisation update CESPHN’s annual update on the latest clinical information on RSV, influenza, COVID-19, emerging diseases and more.
Webinar: Influenza and COVID-19 vaccination update NCIRS latest updates relating to influenza and COVID-19 vaccination, including 2024 Australian Government program recommendations and available vaccines.
Conference (2 days): Benchmarque 2024 Immunisation Conference CESPHN is offering nurses an opportunity to attend a two-day face to face immunisation conference held at the Pullman Sydney Airport (Gadigal Country), valued at $600. More information.
New 2024 COVID-19 recommendations
ATAGI 2024 recommendations for COVID-19 booster doses and primary courses are now available. The following resources have been updated to reflect the 2024 ATAGI advice:
The Australian Immunisation Handbook | COVID-19 Chapter will be updated to reflect 2024 recommendations in the coming weeks.
Booster dose recommendations
Aged 75 years and over
Booster dose recommended every 6 months.
Aged 65 to 74 years
Booster dose recommended every 12 months. Can consider every 6 months.
Aged 18 to 64 years
General population: consider booster dose every 12 months. Severe immunocompromise: booster dose recommended every 12 months. Can consider every 6 months.
Aged 5 to 17 years
General population: booster dose not recommended. Severe immunocompromise: consider booster dose every 12 months.
Under 5 years
Booster dose not recommended.
Primary course recommendations
Aged 18 years and over
Recommend a single dose primary course.
Under 18 years (no risk factors)
Primary course not recommended.
Aged 5 to 18 years
With risk factors: consider a single dose primary course. With severe immunocompromise: recommend a two-dose primary course. Consider a third primary dose.
Aged 6 months to 5 years
With risk factors: consider a two-dose primary course. Consider a third primary dose based on individual risk-benefit assessment. With severe immunocompromise: recommend a two-dose primary course. Consider a third primary dose.
2024 seasonal influenza program
Providers should now be preparing the for the influenza season and take every opportunity to offer influenza vaccination to patients and their family members. Ensure readiness for the influenza season by:
promoting the free NIP vaccine to eligible people and priority groups
considering opportunities to co-administer vaccines – you can give influenza vaccines on the same day as any COVID-19 vaccine
Key information and advice about the 2024 influenza program:
ATAGI information and advice
ATAGI advice for immunisation providers regarding 2024 influenza vaccination is now available.
Key messages:
Influenza vaccination is recommended for all people aged 6 months and over.
Free seasonal influenza vaccine is funded under the NIP for eligible groups at higher risk of complications from influenza.
Influenza vaccine can be co-administered with any COVID-19 vaccine.
Flucelvax Quad, a cell-based influenza vaccine is funded under the NIP in 2024 for at-risk population aged 5 to 64 years. There is no preference for use between Flucelvax Quad and standard dose egg-based influenza vaccines.
Ordering NIP influenza vaccines
First order pre-allocations in 2024 will differ from previous years in line with available vaccine supply from the Commonwealth:
Pre-allocation approval window ends 15 March 2024.
See NSW Health website for further information on 2024 seasonal influenza vaccination.
Department of Health resources
This Department of Health and Aged Care resource collection provides information about getting vaccinated against influenza in 2024, including Information for consumers, advice for health professionals, resources for health care settings and campaign materials.
A free immunisation program to protect young babies and those at risk from RSV was announced by the WA government last week.
In 2024, all babies aged 8 months and under, and at-risk infants aged 8 months to 19 months will be eligible for the immunisation in WA. The RSV immunisation differs from other routine childhood vaccines – it will be a monoclonal antibody (nirsevimab) which was TGA approved in 2023.
For more information, see The Conversation article.
Moderna XBB.1.5 supply update
Moderna (XBB.1.5) 12 years+ PFS vaccine allocations will be reduced from 50 doses to 30 doses per fortnight from the ordering window commencing Saturday 9 March 2024.
The allocations for the Pfizer XBB.1.5 and the Pfizer Bivalent BA.4-5 vaccines have not changed. There are more than sufficient doses of XBB vaccines to ensure everyone in Australia eligible for a 2024 COVID-19 vaccine dose can receive it.
SKAI – Immunisation information for parents
Sharing Knowledge About Immunisation (SKAI) information and resources can help to support immunisation conversations with parents.
Order the SKAI – Parent contact card and encourage parents to access the SKAI website which provides parent-friendly information about immunisation and provides respectful and helpful answers to common questions parents have about immunisation.
Immunisation Weekly Update State Vaccine Centre Christmas closure The State Vaccine Centre will no longer be accepting vaccine orders. Orders placed before midday Tuesday, 19 December will be dispatched Wednesday, 20 December, and routine deliveries will recommence on Tuesday, 2 January 2024. Please do not order excessive stock over this…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: Immunisation education Register for upcoming immunisation education webinars below. View past webinar recordings on our Immunisation | Education webpage. In case you missed it: Introduction to the NIP – webinar recording Practice nurse networking evening Practice nurses are invited to join us for our Nurse networking evening….
Immunisation Weekly Update: Measles alert There have been 10 cases of measles in NSW since 1 January 2024, including two locally acquired cases. NSW Health released a measles alert on 11 April 2024, reminding health providers to consider measles in people arriving from overseas with fever even if previously vaccinated…
Immunisation Weekly Update: Immunisation education View past webinar recordings on our Immunisation | Education webpage. REGISTER30 April 2024 6:00pm – 9:00pmFree event: Respiratory Infections and the Role of VaccinesAn evening of networking, drinks, canapes, and expert talks on respiratory diseases and vaccines. Topics include update on viral epidemiology, management of…
Immunisation Weekly Update: Immunisation education Register for upcoming immunisation education webinars, including CESPHN’s annual immunisation update. View past webinar recordings on our Immunisation | Education webpage. REGISTER 9 April 20241:00pm – 2:00pm Introduction to the National Immunisation Program (NIP) – Lunch and learn series An introduction to the National Immunisation Program…